# Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

> **NCT05974007** · — · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 1500 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Neoadjuvant immunochemotherapy
- **DRUG:** Neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT05974007
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2024-08-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2023-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05974007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05974007, "Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05974007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*